Efficacy and Safety Study for an Oral Contraceptive Containing Folate
Completed · Phase 3
Conditions studied: Neural Tube Defects, Contraception, Oral Contraceptives (OC)
In brief
The purpose of this study is to determine whether the study drug is safe and effective
Key facts
- Study ID
- NCT00468481
- Run by
- Bayer
- People needed
- 385
- Starts
- 2007-04-01
- Expected to finish
- 2008-09-01
- Last updated by the study team
- 2014-04-23
Who can join
Age: 18 and older, up to 40. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Healthy women between 18 and 40 requesting oral contraception
You may not qualify if…
- The use of steroidal oral contraceptives, or any drug that could alter Oral Contraception metabolism will be prohibited during the study
Where it is running
- Orange County Clinical Trials — Anaheim, California, United States
- Medical Center for Clinical Research — San Diego, California, United States
- SNBL Clinical Pharmacology Center, Inc. — Baltimore, Maryland, United States
- Columbia University Medical Center — New York, New York, United States
- AAIPharma, Inc. — Morrisville, North Carolina, United States
- Lyndhurst Gynecologic Associates — Winston-Salem, North Carolina, United States
- Coastal Carolina Research Center — Mt. Pleasant, South Carolina, United States
- New Orleans Center for Clinical Research — Knoxville, Tennessee, United States
- NorthWest Kinetics — Tacoma, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.